TSD freelance contributor Dr. Sybil C. Mitchell is participating in the ongoing Johnson & Johnson COVID-19 vaccine trial. This week she learned the J&J one-shot option is on hold pending a review of concerns that have surfaced about blood clotting in a small number of women. (Courtesy photo)